Not available outside of the UK & Ireland.
Biochem/physiol Actions
α-adrenoceptor agonist; imidazoline binding site ligand.
Features and Benefits
This compound was developed by Novartis. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.
Packaging
5, 25 g in glass bottle
This product has met the following criteria to qualify for the following awards: